Escalating geopolitical tensions and the stalling of the decline in U.S. inflation highlight defensive funds as a smart investment choice. According to Liz Ann Sonders, chief investment strategist at Charles...
Leerink upgraded Aclaris to ‘Outperform’ from ‘Market Perform’ with its price target raised to $7 from $2; Piper Sandler upgraded the company to ‘Overweight’ from ‘Neutral.’
Stocks in these "safe" sectors are selling off as investors gravitate toward growth.
/Walgreens%20Boots%20Alliance%20Inc%20store-%20by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Walgreens Boots Alliance has underperformed the broader market this year, and Wall Street analysts are cautious about the stock’s prospects.
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. Its non-cyclical nature, which provides a cushion to the portfolio in times of economic...
ETFs can be safe yet powerful investments. But there are still risks involved.
/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Danaher recently underperformed the healthcare sector, but Wall Street analysts are moderately bullish about the stock’s prospects.
/Thermo%20Fisher%20Scientific%20Inc_%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Thermo Fisher Scientific recently underperformed the healthcare sector, but Wall Street analysts are bullish about the stock’s prospects.
September could further increase market volatility. Often termed as Wall Street’s worst month, September has been challenging for traders. According to Yahoo Finance, for the past 98 years, September...
/Centene%20Corp_%20logo%20and%20meds-by%20Formatoriginal%20via%20Shutterstock.jpg)
Centene has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.